Suzetrigine

for the treatment of short-term moderate-to-severe pain in adults which is the first of a new class of analgesics that aren't addictive.

The drug is not an opioid, which means that medical professionals now have an alternative to treating pain that doesn't require using a potentially addictive analgesic.

FDA approves new class of painkiller – the first in more than 20 years

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term moderate-to-severe pain in adults. It’s the first of a new class of analgesics to be approved in over 20 years, and, importantly, it isn’t addictive.

https://newatlas.com/medical/fda-new-class-analgesic-suzetrigine/

Suzetrigine

Recommendations